153 related articles for article (PubMed ID: 7989779)
1. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.
Satoh M; Ajmani AK; Ogasawara T; Langdon JJ; Hirakata M; Wang J; Reeves WH
J Clin Invest; 1994 Nov; 94(5):1981-9. PubMed ID: 7962544
[TBL] [Abstract][Full Text] [Related]
3. Anti-RNA polymerase antibodies in systemic sclerosis (SSc): association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II.
Harvey GR; Rands AL; McHugh NJ
Clin Exp Immunol; 1996 Sep; 105(3):468-74. PubMed ID: 8809136
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.
Stojanov L; Satoh M; Dooley MA; Kuwana M; Jennette JC; Reeves WH
Lupus; 1995 Aug; 4(4):314-7. PubMed ID: 8528230
[TBL] [Abstract][Full Text] [Related]
6. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
7. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
[TBL] [Abstract][Full Text] [Related]
8. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay.
Chang M; Wang RJ; Yangco DT; Sharp GC; Komatireddy GR; Hoffman RW
Clin Immunol Immunopathol; 1998 Oct; 89(1):71-8. PubMed ID: 9756726
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
12. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
13. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
14. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
16. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.
Kuwana M; Okano Y; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Feb; 42(2):275-84. PubMed ID: 10025921
[TBL] [Abstract][Full Text] [Related]
18. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
[TBL] [Abstract][Full Text] [Related]
20. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
Radić M; Martinović Kaliterna D; Ljutić D
Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
